Partners4Access was part of this year’s ISPOR conference in Vienna where payers, manufacturers, regulators and politicians met. High profile speakers from national, regional and global bodies discussed different pricing models for pharmaceuticals, their feasibility and importance to create sustainable and fair health systems. Striving towards a fair health system is closely linked to another key topic we followed, balancing value for patients and payers. Healthcare decision making is focused on the patient need to ensure the best possible outcome, but increasing budget pressures and complex procedures make it more difficult to address payer and patient interests at the same time. Listening to lectures and plenary sessions analysing the changing pharmaceutical environment provided us with additional insights and opportunities to optimally support clients on their own journey towards market access.
Partners4Access will continue its exchange with high profile experts in the field of orphan diseases and market access, to ensure consistent delivery of excellence for our clients. If you would like to meet us at one of the next conferences, please get in touch.
ABOUT P4A
Partners4Access is a global consultancy 100% focused on orphan drug access.
The company support the biotechnology and pharmaceutical industry along their launch journey to help secure successful price, reimbursement and access for orphan drugs. Partners4Access has solid partnerships with clients supporting their strategy and operations to effectively ensure launch success.
